CD40 ligation triggers COX-2 expression in endothelial cells: Evidence that CD40-mediated IL-6 synthesis is COX-2-dependent

Inflammation Research

Volumn 52, Issue 1, 2003, Pages 18-25

  Dongari Bagtzoglou, A I ^a   Thienel, U ^b   Yellin, M J ^b  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

CD154; Endothelial cells; Inflammation; Prostaglandins

Indexed keywords

CD40 ANTIGEN; CD40 LIGAND MONOCLONAL ANTIBODY; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; GAMMA INTERFERON; IBUPROFEN; INTERLEUKIN 6; ISOBUTYLMETHYLXANTHINE; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; PROSTACYCLIN; PROSTAGLANDIN E2; PROSTANOID;

ARTICLE; CELL CULTURE; CELL TYPE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG EFFECT; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME SYNTHESIS; HUMAN; HUMAN CELL; MOLECULAR INTERACTION; PROSTAGLANDIN RELEASE; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SUPERNATANT; UPREGULATION; WESTERN BLOTTING;

ANTIGENS, CD40; BLOTTING, WESTERN; CD40 LIGAND; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; CYTOKINES; DINOPROSTONE; ENDOTHELIUM, VASCULAR; HUMANS; INTERFERON TYPE II; INTERLEUKIN-6; ISOENZYMES; MEMBRANE PROTEINS; PHOSPHODIESTERASE INHIBITORS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; PROSTAGLANDINS; UMBILICAL VEINS;

EID: 0037285989     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000110300009     Document Type: Article

References (54)

1. Gilroy D, Colville-Nash PR. New insights into the role of COX-2 in inflammation. J Mol Med 2000; 78: 121-9.
2. Hla T, Ristimaki A, Appleby S, Barriocana JG. Cyclooxygenase gene expression in inflammation and angiogenesis. Ann NY Acad Sci 1993; 696: 197-204.
3. Kurumbail RG, Stevens AM, Gierse JK, McDonald JJ, Stegeman RA, Pak JY et al. Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents. Nature 1996; 384: 644-8.
4. FitzGerald GA, Patrono C. The Coxibs, Selective Inhibitors of Cyclooxygenase-2. N Engl J Med 2001; 345: 433-42.
5. Sano H, Hla T, Maier JA, Crofford LJ, Maciag T, Wilder RL. In Vivo Cyclooxygenase Expression in Synovial Tissues of Patients with Rheumatoid Arthritis and Osteoarthritis and Rats with Adjuvant and Streptococcal Cell Wall Arthritis. J Clin Invest 1992; 89: 97-108.
6. Yellin MJ, Brett J, Baum D, Matsushima A, Szabolcs M, Stern D et al. Functional Interactions of T Cells with Endothelial Cells: The Role of CD40L-CD40-mediated Signals. J Exp Med 1995; 182: 1857-64.
7. Gimbrone MA Jr, Topper JN, Nagel T, Anderson KR, Garcia-Cardena G. Endothelial Dysfunction, Hemodynamic Forces, and Atherogenesis. Ann NY Acad Sci 2000; 902: 230-9.
8. Hla T, Maciag T. COX gene expression is down-regulated by heparin-binding (acidic fibroblast) growth factor-1 in human endothelial cells. J Biol Chem 1991; 266: 24059-63.
9. Cao C, Matsumura K, Yamagata K, Watanabe Y. Endothelial cells of the rat brain vasculature express cyclooxygenase-2 mRNA in response to systemic interleukin-1 beta: a possible site of prostaglandin synthesis responsible for fever. Brain Res 1996; 733: 263-72.
10. 2 Production in Human Lung Fibroblasts. J Immunol 1998; 160: 1053-7.
11. Hollenbaugh D, Mischel-Petty N, Edwards CP, Simon JC, Denfeld RW, Kiener PA et al. Expression of Functional CD40 by Vascular Endothelial cells. J Exp Med 1995; 182: 33-40.
12. Laman JD, De Boer M, Hart BA. CD40 in clinical inflammation: from multiple sclerosis to atherosclerosis. Develop Immunol 1998; 6: 215-22.
13. 2: The Role of p38 Mitogen-Activated Protein Kinase. J Interferon Cyt Res 2000; 20: 291-8.
14. 2. J Biol Chem 1997; 272: 25693-9.
15. 2 production. J Biomed Science 1999; 6: 425-32.
16. Eisengart CA, Mestre JR, Naama HA, Mackrell PJ, Rivadeneira DE, Murphy EM et al. Prostaglandins Regulate Melanoma-Induced Cytokine Production in Macrophages. Cell Immunol 2000; 204: 143-9.
17. Walton LJ, Franklin IJ, Bayston T, Brown LC, Greenhalgh RM, Taylor GW et al. Inhibition of prostaglandin E2 synthesis in abdominal aortic aneurysms: implications for smooth muscle cell viability, inflammatory processes, and the expansion of abdominal aortic aneurysms. Circulation 1999; 100: 48-54.
18. Modeer T, Domeij H, Anduren I, Mustafa M, Brunius G. Effect of phenytoin on the production of interleukin-6 and interleukin-8 in human gingival fibroblasts. J Oral Pathol Med 2000; 29: 491-9.
19. 2 in Human Osteoblasts, MG-63 Cells. J Biochem 199; 126: 553-8.
20. - T cells that induces contact-dependent B cell differentiation (help). J Exp Med 1992; 175: 1091-101.
21. Dongari-Bagtzoglou AI, Warren WD, Berton MT, Ebersole JL. CD40 expression by gingival fibroblasts: correlation of phenotype with function. International Immunol 1997; 9: 1233-41.
22. Kiener PA, Moran-Davis P, Rankin BM, Wahl AF, Aruffo A, Hollenbaugh D. Stimulation of CD40 with Purified Soluble gp39 Induces Proinflammatory Responses in Human Monocytes. J Immunol 1995; 155: 4917-25.
23. Yellin MJ, Winikoff S, Fortune SM, Baum D, Crow MK, Lederman S et al. Ligation of CD40 on fibroblasts induces CD54 (ICAM-1) and CD 106 (VCAM-1) up-regulation and IL-6 production and proliferation. J Leukocyte Biol 1995; 58: 209-16.
24. Futaki N, Takahashi S, Yokoyama M, Arai I, Higuchi S, Otomo S. NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro. Prostaglandins 1994; 47: 55-9.
25. Berg J, Stocher M, Bogner S, Wolff S, Pichler R, Stekel H. Inducible cyclooxygenase-2 gene expression in the human thyroid epithelial cell line Nthy-ori3-1. Inflamm Res 2000; 49: 139-43.
26. 2 in a murine model of inflammation: Possible role of cyclooxygenase-2. Proc Natl Acad Sci USA. 1996; 93: 4885-90.
27. Fosslien E. Molecular pathology of cyclooxygenase-2 in neoplasia. Ann Clin Lab Sci 2000; 30: 3-21.
28. Anderson GD, Hauser SD, McGarity KL, Bremer ME, Isakson PC, Gregory SA. Selective inhibition of cyclooxygenase (COX)-2 reverses inflammation and expression of Cox-2 and interleukin 6 in rat adjuvant arthritis. J Clin Invest 1996; 97: 2672-9.
29. Smith WL. Prostanoid biosynthesis and mechanisms of action. Am Physiol 1992; 263Ž: F181-91.
30. Seeds MC, Bass DA. Regulation and Metabolism of Arachidonic Acid. 1999. Clin Rev Allergy Immunol 1999; 17: 5-21.
31. Miralpeix M, Camacho M, Lopez-Belmonte J, Canalias F, Beleta J, Palacios JM et al. Selective induction of cyclooxygenase-2 activity in the permanent human endothelial cell line HUV-EC-C: biochemical and pharmacological characterization. Br J Pharmacol 1997; 121: 171-80.
32. Schonbeck U, Mach F, Bonnefoy J-Y, Loppnow H, Flad H-D, Libby P. Ligation of CD40 Activates Interleukin 1β-converting Enzyme (Caspase-1) Activity in Vascular Smooth Muscle and Endothelial Cells and Promotes Elaboration of Active Interleukin 1 β. J Biol Chem 1997; 272: 19569-74.
33. Mack Strong VE, Mackrell PJ, Concannon EM, Mestre JR, Smyth GP, Schaefer PA et al. NS-398 treatment after trauma modifies NF-kappaB activation and improves survival. J Surg Res 2001; 98: 40-6.
34. Lin CH, Kuan IH, Lee HM, Lee WS, Sheu JR, Ho YS et al. Induction of cyclooxygenase-2 protein by lipoteichoic acid from Staphylococcus aureus in human pulmonary epithelial cells: involvement of a nuclear factor-kappa B-dependent pathway. Br J Pharmacol 2001; 134: 543-52.
35. Guo F, Li Y, Wu S. Antisense IPAK-2 oligonucleotide blocks IL-1-stimulated NF-kappaB activation and ICAM-1 expression in cultured endothelial cells. Inflammation 1999; 23: 535-43.
36. Lee JR, Koretzky GA. Production of reactive oxygen intermediates following CD40 ligation correlates with c-Jun N-terminal kinase activation and IL-6 secretion in murine B lymphocytes. Eur J Immunol 1998; 28: 4188-97.
37. Hess S, Rensing-Ehl A, Schwabe R, Bufler P, Engelmann H. CD40 Function in Nonhematopoietic Cells. Nuclear Factor κB Mobilization and Induction of IL-6 Production. J Immunol 1995; 155: 4588-95.
38. Bishop-Bailey D, Burke-Gaffney A, Hellewell PG, Pepper JR, Mitchell JA. 1998. Cyclo-oxygenase-2 Regulates Inducible ICAM-1 and VCAM-1 Expression in Human Vascular Smooth Muscle Cells. Biochem Biophys Res Commu 1998; 249: 44-7.
39. Whittaker DS, Bahjat KS, Moldawer LL, Clare-Salzler MJ. Autoregulation of Human Monocyte-Derived Dendritic Cell Maturation and IL-12 Production by Cyclooxygenase-2-Mediated Prostanoid Production. J Immunol 2000; 165: 4298-304.
40. Jeppson JD, Patel HR, Sakata N, Domenico J, Terada N, Gelfand EW. Requirement for Dual Signals by Anti-CD40 and IL-4 for the Induction of Nuclear Factor-κB, 1L-6, and IgE in Human B Lymphocytes. J Immunol 1998; 161: 1738-42.
41. Baccam M, Bishop GA. Membrane-bound CD154, but not CD40-specific antibody, mediates NF-κB-independent IL-6 production in B cells. Eur J Immunol 1999; 29: 3855-66.
42. Berberich I, Shu GL, Clark EA. Cross-linking CD40 in B cells rapidly activates nuclear factor-kappa B. J Immunol 1994; 153: 4357-66
43. Chen BC, Lin WW. Pyrimidinoceptor potentiation of macrophage PGE(2) release involved in the induction of nitric oxide synthase. Br J Pharmacol 2000; 130: 777-86.
44. Dongari-Bagtzoglou AI, Ebersole JL. Increased presence of interleukin-6 (IL-6) and IL-8 secreting fibroblast subpopulations in adult periodontitis. J Periodontol 1998; 69: 899-910.
45. Sinha-Morton R, Dongari-Bagtzoglou AI. COX-2 expression is upregulated in inflamed gingival tissues. J Periodontol 2001; 72: 461-9.
46. Arend WP, Dayer JM. Cytokines & cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheum 1990; 33: 305-15.
47. Hong BK, Kwon HM, Lee BK, Kim IJ, Kang SM, Jang Y et al. Coexpression of cyclooxygenase-2 and matrix metalloproteinases in human aortic atherosclerotic lesions. Yonsei Med J 2000; 41: 82-8.
48. Belton O, Byrne D, Kearney D, Leahy A, Fitzgerald DJ. Cyclooxygenase-1 and -2-dependent prostacyclin formation in patients with atherosclerosis. Circulation 2000; 102: 840-5.
49. Potocnik A, Kinne R, Menninger H, Zacher J, Emmrich F, Kroczek RA. Expression of activation antigens on T cells in rheumatoid arthritis patients. Scand J Immunol 1990; 31: 213-7.
50. Mach F, Schonbeck U, Sukhova G, Bourcier T, Bonnefoy J-Y, Pober JS et al. Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: Implications for CD40-CD40 ligand signaling in atherosclerosis. Proc Natl Acad Sci USA 1997; 94: 1931-6.
51. Szabolcs MJ, Cannon PJ, Thienel U, Chen R, Michler RE, Chess L et al. Analysis of CD154 and CD40 expression in native coronary atherosclerosis and transplant associated coronary artery disease. Virchows Arch 2000; 437: 149-59.
52. Orima K, Yamazaki K, Aoyagi T, Hara K. Differential expression of costimulatory molecules in chronic inflammatory periodontal disease tissue. Clin Exp Immunol 1999; 115: 153-60.
53. Durie F, Faua R, Foy T, Aruffo A, Ledbetter JL, Noelle R. Prevention of collagen induced arthritis with an antibody to gp39, the ligand for CD40. Science 1993; 261: 1328-30.
54. Adawi A, Zhang Y, Baggs R, Rubin P, Williams J, Finkelstein J et al. Blockade of CD40-CD40 Ligand Interactions Protects against Radiation-Induced Pulmonary Inflammation and Fibrosis. Clin Immunol Immunopathol 1998; 89: 222-30.